[LXRX] YoY Quarter Result on 31-Mar-2020 [#Q1]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
27-Apr-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q1]
Profit Trend
QoQ- -30.26%
YoY- -205.60%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
Revenue 24 37 27 7,999 9,216 25,207 18,293 -66.89%
PBT -31,934 -23,476 -20,958 -66,611 -21,797 -42,075 -43,543 -5.03%
Tax -1,029 96 48 958 789 6,119 -8,652 -29.86%
NP -30,905 -23,572 -20,958 -66,611 -21,797 -42,075 -34,891 -2.00%
Tax Rate - - - - - - - -
Total Cost 30,929 23,609 20,985 74,610 31,013 67,282 53,184 -8.63%
Ratio Analysis
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
NP Margin -128,770.83 -63,708.11 -77,622.22 -832.74 -236.51 -166.92 -190.73 196.04%
Per Share
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
EPS -0.16 -0.16 -0.15 -0.63 -0.21 -0.40 -0.33 -11.36%
EPS Diluted -0.16 -0.16 -0.15 -0.63 -0.21 -0.40 -0.33 -11.36%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.